Sio Capital Management, LLC
NEW YORK, NY · CIK 1482416 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entitySIO CAPITAL MANAGEMENT, LLC (US)
$583.5m
reported value
-15.9% vs Q1 2026
57positions
50.1%in top 10
15 new
10 added
21 reduced
31 sold out
vs Q1 2026
Options: 1 call positions ($2.6m notional), 1 put positions ($18.2m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ANTERIS TECHNOLOGIES GLOBAL AVR | $54.6m9.36% | Added +163.0k |
| CENCORA INC COR | $49.1m8.42% | Added +72.7k |
| MAXIMUS INC MMS | $38.5m6.59% | Reduced -53.6k |
| ALLOGENE THERAPEUTICS INC ALLO | $27.7m4.75% | New |
| GLOBUS MED INC GMED | $23.8m4.09% | New |
| GSK PLC GSK | $22.9m3.92% | Added +50.8k |
| TYRA BIOSCIENCES INC TYRA | $22.2m3.81% | Added +89.9k |
| WAYSTAR HLDG CORP WAY | $19.0m3.26% | Reduced -716.4k |
| IDEAYA BIOSCIENCES INC IDYA | $17.9m3.07% | New |
| ORUKA THERAPEUTICS INC ORKA | $16.9m2.89% | Added +44.6k |
| THE CIGNA GROUP CI | $15.9m2.73% | New |
| SANOFI SNY | $15.5m2.66% | Added +124.5k |
| ICON PLC ICLR | $15.3m2.63% | Reduced -218.2k |
| VIATRIS INC VTRS | $15.2m2.60% | New |
| CROSS CTRY HEALTHCARE INC CCRN | $14.5m2.49% | Unchanged |
| RAPPORT THERAPEUTICS INC RAPP | $12.8m2.20% | Reduced -59.2k |
| ABBOTT LABS ABT | $11.7m2.00% | Reduced -57.9k |
| CELCUITY INC CELC | $11.5m1.97% | Reduced -83.8k |
| ZIMMER BIOMET HOLDINGS INC ZBH | $11.3m1.94% | Added +68.8k |
| REGENERON PHARMACEUTICALS REGN | $11.2m1.92% | New |
| BRISTOL-MYERS SQUIBB CO BMY | $11.1m1.91% | New |
| MEDTRONIC PLC MDT | $11.1m1.91% | New |
| VIR BIOTECHNOLOGY INC VIR | $11.0m1.88% | Reduced -423.3k |
| SENSEONICS HLDGS INC SENS | $9.0m1.55% | Added +1.5m |
| EYEPOINT PHARMACEUTICALS INC EYPT | $8.9m1.53% | Reduced -98.7k |
| CYBIN INC COM NEW | $8.6m1.47% | New |
| ANI PHARMACEUTICALS INC ANIP | $8.1m1.38% | Reduced -168.2k |
| PROTARA THERAPEUTICS INC TARA | $7.3m1.26% | Reduced -48.0k |
| RELMADA THERAPEUTICS INC RLMD | $6.9m1.19% | Added +38.6k |
| TANGO THERAPEUTICS INC TNGX | $6.5m1.12% | New |
| AQUESTIVE THERAPEUTICS INC AQST | $6.2m1.06% | Reduced -436.7k |
| DIANTHUS THERAPEUTICS INC DNTH | $5.8m0.99% | Reduced -310.8k |
| SIONNA THERAPEUTICS INC SION | $5.6m0.96% | Reduced -166.5k |
| OCULAR THERAPEUTIX INC OCUL | $5.3m0.91% | Reduced -429.1k |
| ZENAS BIOPHARMA INC ZBIO | $5.3m0.91% | Reduced -123.2k |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $5.2m0.89% | Reduced -12.1k |
| ONKURE THERAPEUTICS INC OKUR | $4.9m0.84% | Unchanged |
| SAVARA INC SVRA | $3.8m0.65% | Added +3.8k |
| PMV PHARMACEUTICALS INC PMVP | $3.5m0.60% | Reduced -442.4k |
| AVEANNA HEALTHCARE HLDGS INC AVAH | $3.2m0.54% | New |
| OVID THERAPEUTICS INC OVID | $2.7m0.46% | Reduced -247.0k |
| IMMUNOME INC IMNM | $2.6m0.45% | Reduced -40.9k |
| AN2 THERAPEUTICS INC ANTX | $2.6m0.44% | Reduced -127.3k |
| SERINA THERAPEUTICS INC SER | $1.9m0.33% | Unchanged |
| ALIGOS THERAPEUTICS INC ALGS | $1.9m0.32% | Unchanged |
| IBIO INC IBIO | $1.6m0.27% | Unchanged |
| XILIO THERAPEUTICS INC XLO | $1.5m0.25% | Unchanged |
| ARTIVION INC AORT | $1.1m0.19% | New |
| BRIDGEBIO ONCOLOGY THERAPEUT BBOT | $995.4k0.17% | Unchanged |
| TELA BIO INC TELA | $477.2k0.08% | Unchanged |
| ADAGIO MED HLDGS INC ADGM | $455.5k0.08% | Reduced -589.5k |
| NEUROONE MED TECHNOLOGIES CO NMTC | $251.6k0.04% | New |
| ENVERIC BIOSCIENCES INC ENVB | $248.4k0.04% | New |
| MODULAR MED INC MODD | $117.9k0.02% | Unchanged |
| QT IMAGING HLDGS INC QTI | $62.0k0.01% | New |
| ROCKET PHARMACEUTICALS INC *W EXP 09/02/202 | $1.5k0.00% | Unchanged |
| HUMACYTE INC HUMAW | $4770.00% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| CORCEPT THERAPEUTICS INC CORT | $27.2m674.8k shares |
| LIVANOVA PLC LIVN | $26.8m421.6k shares |
| EMBECTA CORP EMBC | $16.3m1.8m shares |
| ABIVAX SA ABVX | $15.1m135.8k shares |
| HAEMONETICS CORP MASS HAE | $12.4m220.7k shares |
| TELEFLEX INCORPORATED TFX | $11.3m94.8k shares |
| BIOMARIN PHARMACEUTICAL INC BMRN | $11.0m194.2k shares |
| STRUCTURE THERAPEUTICS INC GPCR | $10.1m209.1k shares |
| BIOHAVEN LTD BHVN | $9.8m1.2m shares |
| MONOPAR THERAPEUTICS INC MNPR | $9.5m173.5k shares |
| CRINETICS PHARMACEUTICALS IN CRNX | $9.1m249.9k shares |
| EDGEWISE THERAPEUTICS INC EWTX | $8.5m269.0k shares |
| COMPASS PATHWAYS PLC CMPS | $8.3m1.5m shares |
| QUIDELORTHO CORP QDEL | $5.9m359.0k shares |
| REPLIMUNE GROUP INC REPL | $5.5m720.0k shares |
| ORGANON & CO OGN | $5.2m865.9k shares |
| DISC MEDICINE INC IRON | $4.2m65.2k shares |
| INTEGRA LIFESCIENCES HLDGS C IART | $3.6m383.1k shares |
| PROQR THRAPEUTICS N V PRQR | $3.2m2.0m shares |
| SHOULDER INNOVATIONS INC SI | $3.1m210.6k shares |
| KYMERA THERAPEUTICS INC KYMR | $2.7m32.2k shares |
| CONTEXT THERAPEUTICS INC CNTX | $2.4m917.9k shares |
| HYPERFINE INC HYPR | $1.1m1.0m shares |
| FOGHORN THERAPEUTICS INC FHTX | $587.4k122.9k shares |
| TERNS PHARMACEUTICALS INC | $532.5k10.1k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP I SLS · Put | $18.2m1.2m shares | New |
| HIMS & HERS HEALTH INC HIMS · Call | $2.6m75.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| SERINA THERAPEUTICS INC SER · 13G · filed 2026-05-04 | 6.7%≈ $1.9m |
| ANTERIS TECHNOLOGIES GLOBAL AVR · 13G · filed 2026-05-04 | 5.5%≈ $53.0m |
| ALIGOS THERAPEUTICS INC ALGS · 13G · filed 2026-02-11 | 5.5%≈ $1.9m |
| APREA THERAPEUTICS INC 13G · filed 2025-02-10 | 5.1% |